ALZN vs MTB · $2.4M cap vs P/E 12, rev $860.0M
Alzamend Neuro Inc (ALZN) versus M&T Bank Corporation (MTB) — a side-by-side from cached financials, not a winner call.
Alzamend Neuro Inc (ALZN) is a biotechnology company listed on US.
M&T Bank Corporation (MTB) is a banks - regional company listed on US.
ALZN does not have a complete income-statement cache yet.
Latest reported MTB revenue for 2026-06-30 was $860.0M. Net income was $1.48B. MTB currently screens at market cap $30.99B and trailing P/E 11.9.
ALZN currently screens at market cap $2.4M. MTB currently screens at market cap $30.99B and trailing P/E 11.9.
Not investment advice. Open the ALZN and MTB stock pages for the full models.
Not investment advice.